viernes, 15 de diciembre de 2023

FDA approves belzutifan for advanced renal cell carcinoma

https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-belzutifan-advanced-renal-cell-carcinoma?utm_medium=email&utm_source=govdelivery

No hay comentarios:

Publicar un comentario